MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series

• Main Authors: Rodolfo Mauceri (Author), Martina Coppini (Author), Massimo Attanasio (Author), Alberto Bedogni (Author), Giordana Bettini (Author), Vittorio Fusco (Author), Amerigo Giudice (Author), Filippo Graziani (Author), Antonia Marcianò (Author), Marco Nisi (Author), Gaetano Isola (Author), Rosalia Maria Leonardi (Author), Giacomo Oteri (Author), Corrado Toro (Author), Giuseppina Campisi (Author)
• Format: Book
• Published: BMC, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Cancer treatment-induced bone loss (CTIBL) is the most common adverse event experienced by patients affected by breast cancer (BC) patients, without bone metastases. Bone modifying agents (BMAs) therapy is prescribed for the prevention of CTIBL, but it exposes patients to the ris...